Literature DB >> 9017106

Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer.

J M Church1.   

Abstract

Prophylactic colectomy is indicated in patients whose colons are at very high risk of developing cancer. Familial adenomatous polyposis (FAP) is the best example of a situation where prophylactic surgery is clearly necessary to prevent cancer, and has been shown to be effective in doing so. Recent advances in the molecular genetics of colorectal cancer have allowed presymptomatic diagnosis of patients with another dominantly inherited syndrome, hereditary nonpolyposis colorectal cancer (HNPCC). Prior to this, prophylactic colectomy had not been a consideration for patients in HNPCC families. A review of the outcome of colectomy and ileorectal anastomosis in FAP patients shows that although it is a major abdominal surgery there is a relatively low complication rate and the functional outcome is acceptable for a prophylactic procedure. The decision to apply colectomy to HNPCC patients depends on careful consideration of factors such as comorbidity, age, sphincter function, likely compliance with future surveillance and likely efficiency of colonoscopy as a cancer prevention strategy. In general, prophylactic colectomy is indicated in HNPCC gene carriers, because their lifetime risk for colorectal cancer is 80%.

Entities:  

Mesh:

Year:  1996        PMID: 9017106     DOI: 10.3109/07853899608999111

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  12 in total

Review 1.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

Review 2.  Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

Authors:  Henry T Lynch; Stephen Lanspa; Trudy Shaw; Murray Joseph Casey; Marc Rendell; Mark Stacey; Theresa Townley; Carrie Snyder; Megan Hitchins; Joan Bailey-Wilson
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

3.  Study of the Annexin A1 and Its Associations with Carcinoembryonic Antigen and Mismatch Repair Proteins in Colorectal Cancer.

Authors:  Lenuce Ribeiro Aziz Ydy; Gilmar Ferreira do Espírito Santo; Ivana de Menezes; Michelle Santos Martins; Eliane Ignotti; Amílcar Sabino Damazo
Journal:  J Gastrointest Cancer       Date:  2016-03

Review 4.  The role of prophylactic surgery in cancer prevention.

Authors:  Y Nancy You; Vipul T Lakhani; Samuel A Wells
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

Review 5.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

6.  Treatment of Hereditary Colorectal Cancer Syndromes.

Authors:  Elizabeth E. Half; Robert S. Bresalier
Journal:  Curr Treat Options Gastroenterol       Date:  2004-06

Review 7.  Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome.

Authors:  Gabriela Möslein; Steffen Pistorius; Hans-Detlev Saeger; Hans K Schackert
Journal:  Langenbecks Arch Surg       Date:  2003-03-27       Impact factor: 3.445

8.  Genetic detection of Chinese hereditary nonpolyposis colorectal cancer.

Authors:  Long Cui; Hei-Ying Jin; Hui-Yu Cheng; Yu-Di Yan; Rong-Gui Meng; De-Hong Yu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

9.  Health behaviors in patients and families with hereditary colorectal cancer.

Authors:  Allison M Burton; Shelly R Hovick; Susan K Peterson
Journal:  Clin Colon Rectal Surg       Date:  2012-06

10.  Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.